Thomas Carell hält Vortrag beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“
Continue readingCNATM Speaker Prof. Dr. Dr. Stefan Engelhardt elected to the German National Academy of Sciences Leopoldina
Great News for CNATM!
Thomas Carell hält Vortrag beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“
Continue readingRNATICS Secures €2.7 Million BMFTR Grant RCS-21 Advances in Clinical Development
Thomas Carell hält Vortrag beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“
Continue readingCluster of Excellence explores RNA and DNA
Thomas Carell hält Vortrag beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“
Continue readingThomas Carell beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“ in Cambridge
Thomas Carell hält Vortrag beim Novo Nordisk Symposium „Frontiers in Biophysics and Chemical Biology“
Continue readingLMU spin-off RNhale GmbH receives millions in funding
LMU spin-off RNhale GmbH receives millions in funding
20. March 2025
The RNhale GmbH, an LMU spin-off, has received 2.5 million euros in funding from the European Innovation Council (EIC). The company will use the funds to further work on the realization of a drug for the treatment of asthma.
Epicure wins the Science4Life Venture Cup
Epicure wins the Science4Life Venture Cup
19. March 2025
Das Startup Epicure wurde bei den Academy Days von Science4Life als eines von 5 Startups mit dem Science4Life Venture Cup ausgezeichnet.
LMU spin-off QuGen GmbH founded!
LMU spin-off QuGen GmbH founded!
18. September 2023
QuGen GmbH, founded by Thomas carell and Pascal Giehr, provides high-sensitive long read sequencing (PacBio), bisulfite-free sequencing of DNA methylation and mass spectrometry quantification of non-canonical nucleobases in DNA and RNA. This includes also sample preparation and data analysis. With this QuGen fulfills unmet needs in quantification and positional information of epigenetic nucleobases.
ERC Starting Grant for Dr. Daniel Andergassen
ERC Starting Grant for Dr. Daniel Andergassen
November 2023
Dr Daniel Andergassen received an ERC Starting Grant for his research on the molecular causes of gender-specific differences in heart failure.
m4 Award for Prof. Urlike Protzer and her Project TherVacB
m4 Award for Prof. Urlike Protzer and her Project TherVacB
25. October 2023
Prof. Ulrike Protzer and her project TherVacB was one of the 5 winners of the Bavarian m4 Award from BioM. TherVacB is a project for the development of a therapeutic vaccine against Hepatitis B virus.
The m4 Award is a pre-funding award for innovative, high-potential medical biotechnology projects, with prize funds to further explore solutions to innovative medical problems.